NCT00147160View on ClinicalTrials.gov

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

December 31, 2007

Conditions
Glioma
Interventions
DRUG

Temozolomide, Cisplatinum

Trial Locations (2)

94805

Institut Gustave-Roussy, Villejuif

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT00147160 - Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents | Biotech Hunter | Biotech Hunter